Home > Income Statement > WINDLAS BIOTECH

WINDLAS BIOTECH
Revenue

    Back to Income Statement
AD     Remove this Ad

WINDLAS BIOTECH Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹760 Cr₹631 Cr₹513 Cr₹466 Cr₹428 Cr

What is the latest Revenue of WINDLAS BIOTECH ?

The latest Revenue ratio of WINDLAS BIOTECH is ₹760 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹760 Cr
Mar2024₹631 Cr
Mar2023₹513 Cr
Mar2022₹466 Cr
Mar2021₹428 Cr

How is Revenue of WINDLAS BIOTECH Trending?

Years Revenue % Change
Mar2025 ₹760 Cr
20.43
Mar2024 ₹631 Cr
22.97
Mar2023 ₹513 Cr
10.12
Mar2022 ₹466 Cr
8.96
Mar2021 ₹428 Cr -

Compare Revenue of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,595.7 Cr -2.8% -7.6% -5.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,028.0 Cr 3.5% 12.3% 5.6% Stock Analytics
DIVIS LABORATORIES ₹170,237.0 Cr 2.8% 7.2% 7.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,801.0 Cr 3.8% 12.1% 42.8% Stock Analytics
CIPLA ₹108,861.0 Cr 1.2% 2.8% -9.1% Stock Analytics
DR REDDYS LABORATORIES ₹107,435.0 Cr 3% 9.1% 11.6% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

-2.8%

-7.6%

-5.1%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses